Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

Heritage Cannabis affiliate Endocanna enters strategic partnership with OMNI Medical Services

“The partnership between OMNI and Endocanna will help accelerate the understanding of the medical benefits of cannabis, including the exciting potential for the use of cannabis products in the treatment of and recovery for those experiencin

Heritage Cannabis Holdings Corp (CSE:CANN, OTCQX:HERTF) has announced that Endocanna Health, a company in which it holds a 30% non-controlling interest, has entered into a strategic partnership with OMNI Medical Services to examine the benefits of using cannabis as a treatment for ailments including coronavirus (COVID-19).

Under the partnership, Heritage said OMNI is preparing a major study in collaboration with Endocanna to determine the best strain of plant-based medicines for patients by analyzing their endocannabinoid system.

Endocanna’s EndoDNA test kits analyze essential biomolecules in the human endocannabinoid system to formulate and identify the ratios of CBD and cannabis the body metabolizes most effectively and explore optimal methods of consumption and dosing based on metabolic function and drug to drug interactions.

READ: Heritage Cannabis signs commercial agreement with Canopy Growth for the supply of bulk concentrates, including live resin

“We are impressed with the advancements being made by Endocanna in helping medical cannabis patients discover their own unique responses to cannabinoids and terpenes,” Heritage CEO David Schwede said in a statement.

“The partnership between OMNI and Endocanna will help accelerate the understanding of the medical benefits of cannabis, including the exciting potential for the use of cannabis products in the treatment of and recovery for those experiencing COVID-19.”

OMNI is a multi-state operator of medical cannabis clinics, evaluations, research, pain management, and online pharmacy services.

Heritage Cannabis is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the US, operating under two licensed manufacturing facilities in Canada.

The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, feelgood., CB4 suite of medical products in Canada, and ArthroCBD in the US.

Contact the author at stephen.gunnion@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK